Fig. 5From: Efficacy of PD-1/PD-L1 inhibitors in ovarian cancer: a single-arm meta-analysisSummary overall response rate for platinum-resistant and platinum-sensitive ovarian cancer excluding treatment arms with a single PD-1/PD-L1 inhibitorBack to article page